Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB00661_nanopub.RAf6Q4OvWJeRwdL7TixGv6FBRg0uCDHns6R2ivrglD8Ls#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB00661 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB00661 label "DDI between Trazodone and Verapamil - The CYP3A4 inhibitor, Verapamil, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Verapamil is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB00661]" assertion.
- drugbank_resource:DB00656_DB00661 identifier "drugbank_resource:DB00656_DB00661" assertion.
- drugbank_resource:DB00656_DB00661 title "DDI between Trazodone and Verapamil - The CYP3A4 inhibitor, Verapamil, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Verapamil is initiated, discontinued or dose changed." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00661 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00661 assertion.